Cocrystal Pharma

COCPNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$19.456 M

$1.01 +0.00%

Close of 6 Nov 2026

As of 6 Nov 2026, Cocrystal Pharma (COCP) has a market capitalization of $19.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$8.83M

Loss-making

Shares outstanding

19,263,200

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#384TherapeuticsMDTXMD$20.0M
#385Aytu BiopharmaAYTU$19.9M
#386Cocrystal PharmaCOCP$19.5M
#387Quoin PharmaceuticalsQNRX$18.5M
#388Actuate TherapeuticsACTU$18.4M

Insiders buying

All insider buying →

2 open-market purchases by officers and directors of Cocrystal Pharma, worth $80.4K. Grants and option exercises are excluded.

Phillip Md Et Al Frost$9.82K
10,000 shares at $0.98 on 5 Aug 2026 · filed 6 Aug 2026
Phillip Md Et Al Frost$70.6K
75,000 shares at $0.94 on 3 Aug 2026 · filed 5 Aug 2026

What if Cocrystal Pharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,465,845

Per share 1,451,332× higher

Bitcoin $1.53T

$79,314.34

Per share 78,529× higher

Apple $5.02T

$260,381.59

Per share 257,804× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Cocrystal Pharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.